Laboratory Corporation of America Holdings

Symbol: LH

NYSE

206.15

USD

Market price today

  • 40.0305

    P/E Ratio

  • 2.3218

    PEG Ratio

  • 17.38B

    MRK Cap

  • 0.01%

    DIV Yield

Laboratory Corporation of America Holdings (LH) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.27%

Operating Profit Margin

0.09%

Net Profit Margin

0.04%

Return on Assets

0.03%

Return on Equity

0.05%

Return on Capital Employed

0.09%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO:Mr. Adam H. Schechter
Full-time employees:67000
City:Burlington
Address:358 South Main Street
IPO:1990-03-29
CIK:0000920148

Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations and accountable care organizations. It offers end-to-end drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, pharmaceutical, biotechnology, medical device and diagnostics companies, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

General Outlook

When we look at how much money they make before expenses, they keep 0.268% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.088%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.035%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.026% return, is a testament to Laboratory Corporation of America Holdings's adeptness in optimizing resource deployment. Laboratory Corporation of America Holdings's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.053%. Furthermore, the proficiency of Laboratory Corporation of America Holdings in capital utilization is underscored by a remarkable 0.086% return on capital employed.

Stock Prices

Laboratory Corporation of America Holdings's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $204.09, while its low point bottomed out at $198.43. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Laboratory Corporation of America Holdings's stock market.

Liquidity Ratios

Analyzing LH liquidity ratios reveals its financial health of the firm. The current ratio of 87.70% gauges short-term asset coverage for liabilities. The quick ratio (58.44%) assesses immediate liquidity, while the cash ratio (2.52%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio87.70%
Quick Ratio58.44%
Cash Ratio2.52%

Profitability Ratios

LH profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 4.83% underscores its earnings before tax deductions. The effective tax rate stands at 32.61%, revealing its tax efficiency. The net income per EBT, 72.91%, and the EBT per EBIT, 55.17%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 8.75%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin4.83%
Effective Tax Rate32.61%
Net Income per EBT72.91%
EBT per EBIT55.17%
EBIT per Revenue8.75%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.88, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding58
Days of Inventory Outstanding19
Operating Cycle84.65
Days of Payables Outstanding54
Cash Conversion Cycle30
Receivables Turnover5.58
Payables Turnover6.70
Inventory Turnover18.96
Fixed Asset Turnover4.24
Asset Turnover0.74

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 13.99, and free cash flow per share, 7.95, depict cash generation on a per-share basis. The cash per share value, 1.18, showcases liquidity position. A payout ratio of 0.58 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.10, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share13.99
Free Cash Flow per Share7.95
Cash per Share1.18
Payout Ratio0.58
Operating Cash Flow Sales Ratio0.10
Free Cash Flow to Operating Cash Flow Ratio0.57
Cash Flow Coverage Ratio0.22
Short Term Coverage Ratio0.53
Capital Expenditure Coverage Ratio2.31
Dividend Paid and Capex Coverage Ratio1.55
Dividend Payout Ratio0.01

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 31.86%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.66, we discern the balance between debt and equity financing. The long-term debt to capitalization, 27.69%, and total debt to capitalization, 39.82%, ratios shed light on its capital structure. An interest coverage of 5.50 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio31.86%
Debt Equity Ratio0.66
Long Term Debt to Capitalization27.69%
Total Debt to Capitalization39.82%
Interest Coverage5.50
Cash Flow to Debt Ratio0.22
Company Equity Multiplier2.08

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 139.63, provides a glimpse into top-line earnings distributed across each share. Net income per share, 4.80, reflects the portion of profit attributed to each share. The book value per share, 90.41, represents the net asset value distributed per share, while the tangible book value per share, -18.30, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share139.63
Net Income Per Share4.80
Book Value Per Share90.41
Tangible Book Value Per Share-18.30
Shareholders Equity Per Share90.41
Interest Debt Per Share62.30
Capex Per Share-5.21

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -18.25%, indicates top-line expansion, while the gross profit growth, -28.28%, reveals profitability trends. EBIT growth, -36.65%, and operating income growth, -36.65%, offer insights into operational profitability progression. The net income growth, -67.32%, showcases bottom-line expansion, and the EPS growth, -65.81%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-18.25%
Gross Profit Growth-28.28%
EBIT Growth-36.65%
Operating Income Growth-36.65%
Net Income Growth-67.32%
EPS Growth-65.81%
EPS Diluted Growth-65.83%
Weighted Average Shares Growth-4.39%
Weighted Average Shares Diluted Growth-4.37%
Dividends per Share Growth36.10%
Operating Cash Flow Growth-32.12%
Free Cash Flow Growth-40.70%
10-Year Revenue Growth per Share106.02%
5-Year Revenue Growth per Share24.93%
3-Year Revenue Growth per Share-2.81%
10-Year Operating CF Growth per Share59.57%
5-Year Operating CF Growth per Share18.41%
3-Year Operating CF Growth per Share-30.54%
10-Year Net Income Growth per Share-28.32%
5-Year Net Income Growth per Share-44.93%
3-Year Net Income Growth per Share-69.99%
10-Year Shareholders Equity Growth per Share212.29%
5-Year Shareholders Equity Growth per Share31.51%
3-Year Shareholders Equity Growth per Share-6.01%
Receivables Growth-30.45%
Inventory Growth0.85%
Asset Growth-17.02%
Book Value per Share Growth-18.42%
Debt Growth-5.41%
SGA Expenses Growth1.24%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 25,214,359,001, captures the company's total value, considering both debt and equity. Income quality, 3.50, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 56.71%, indicates the value of non-physical assets, and capex to operating cash flow, -34.16%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value25,214,359,001
Income Quality3.50
Research and Development to Revenue0.02%
Intangibles to Total Assets56.71%
Capex to Operating Cash Flow-34.16%
Capex to Revenue-3.73%
Capex to Depreciation-78.09%
Stock-Based Compensation to Revenue1.06%
Graham Number98.81
Return on Tangible Assets5.77%
Graham Net Net-74.47
Working Capital540,200,000
Tangible Asset Value-1,594,000,001
Net Current Asset Value-5,069,200,000
Invested Capital1
Average Receivables2,558,049,999.5
Average Payables881,150,000
Average Inventory472,600,000
Days Sales Outstanding63
Days Payables Outstanding33
Days of Inventory On Hand19
ROIC5.73%
ROE0.05%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.18, and the price to book ratio, 2.18, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.41, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 26.01, and price to operating cash flows, 14.73, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.18
Price to Book Ratio2.18
Price to Sales Ratio1.41
Price Cash Flow Ratio14.73
Price Earnings to Growth Ratio2.32
Enterprise Value Multiple6.74
Price Fair Value2.18
Price to Operating Cash Flow Ratio14.73
Price to Free Cash Flows Ratio26.01
Price to Tangible Book Ratio2.51
Enterprise Value to Sales2.07
Enterprise Value Over EBITDA14.79
EV to Operating Cash Flow18.99
Earnings Yield2.11%
Free Cash Flow Yield4.42%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Laboratory Corporation of America Holdings (LH) on the NYSE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 40.031 in 2024.

What is the ticker symbol of Laboratory Corporation of America Holdings stock?

The ticker symbol of Laboratory Corporation of America Holdings stock is LH.

What is company IPO date?

IPO date of Laboratory Corporation of America Holdings is 1990-03-29.

What is company current share price?

Current share price is 206.150 USD.

What is stock market cap today?

The market cap of stock today is 17377125640.000.

What is PEG ratio in 2024?

The current 2.322 is 2.322 in 2024.

What is the number of employees in 2024?

In 2024 the company has 67000.